During acute infections, a small population of effector CD8 + T cells evades terminal
differentiation and survives as long-lived memory T cells. We demonstrate that the transcriptional …

We describe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cell
responses, soluble markers of inflammation, and antibody levels and neutralization capacity …

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the
virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory …

As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae
following COVID-19 recovery. Mechanisms to explain long-term neurological sequelae are …

It is unclear where within tissues subsets of effector and memory CD8 T cells persist during
viral infection and whether their localization affects function and long-term survival. Following …

Interpretation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serosurveillance studies is limited by poorly defined performance of antibody assays over time in …

In response to acute infections or vaccines, naive antigen‐specific CD8 + T cells proliferate
and differentiate into effector cytotoxic lymphocytes that acquire the ability to kill infected cells…

Background There is mounting evidence for the presence of postacute sequelae of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), but there is limited …

Many HIV-infected individuals on antiretroviral therapy (ART) exhibit persistent systemic
inflammation, which predicts morbidity and mortality. ART-treated subjects concurrently exhibit …

Background: Limited data are available on the long-term clinical and immunologic consequences
of SARS-CoV-2 infection in people with HIV (PWH). Methods: We measured SARS-…